Am J Physiol Heart Circ Physiol 291: H1959 –H1971, 2006. First published April 28, 2006; doi:10.1152/ajpheart.00956.2005. L-type calcium channel ␣-subunit and protein kinase inhibitors modulate Rem-mediated regulation of current Shawn M. Crump,1 Robert N. Correll,2 Elizabeth A. Schroder,1 William C. Lester,1 Brian S. Finlin,2 Douglas A. Andres,2 and Jonathan Satin1 Departments of 1Physiology and 2Biochemistry, University of Kentucky College of Medicine, Lexington, Kentucky Submitted 7 September 2005; accepted in final form 20 April 2006 CARDIAC L-type Ca channel (CaV1.2) current is a major determinant of excitable cell function, and CaV1.2 function is tightly regulated by intracellular signaling systems. CaV1.2 is both an initiator and integrator of diverse signaling pathways. As an initiator of cell signaling, CaV1.2 regulates cytosolic Ca entry and cell excitability. As an integrator of cell signaling, a diverse array of intracellular pathways, including but not limited to PKA, CaM, CaMK, and protein phosphatase 2B, regulate Ca channel function. For example, PKA mediates phos- phorylation of CaV1.2 on the COOH terminus, leading to a marked increase of Ca channel current (18). The cardiac L-type Ca channel complex consists of multiple subunits, CaV1.2 being the main pore-forming ␣-subunit (8). In addition, auxiliary subunits in the heart include CaV2 and ␣2-␦ subunits. All of the subunits contribute to shaping the kinetics and voltage dependence of channel gating (8, 16, 28, 29, 32). However, CaV2 has the important role of enhancing Ca channel expression levels in myocytes (12, 51) and in heterologous expression systems (6, 10, 24, 52). Within the CaV2 family, CaV2a most effectively retards voltage-dependent inactivation of current (49). Thus the time course of current decay can serve as index of the degree of CaV interaction with functioning channels. We recently described the members of the Rad and Gem/Kir-related (RGK) family of small G-binding proteins as a novel class of Ca channel regulators. RGK proteins include Rem, Rem2, Kir/Gem, and Rad. RGK GTPases bind to CaV (1, 20) and inhibit CaV1 current expression in muscle cells (20) and in heterologous expression systems (1, 20). RGK protein overexpression can be used as an extrinsic mechanism for native cardiac Ca channel block (34). The RGK protein Rem (19) is expressed in cardiac tissue, yet Rem coexpressed with CaV2 prevents expression of L-type Ca current (ICa,L) (1, 20). This raises the puzzling question of how excitable cells maintain ICa,L in the presence of endogenous RGK proteins such as Rem. One possibility is that Rem-CaV regulation of ICa,L is regulated by intracellular signaling systems. Initial work on RGK inhibition of ICa,L investigated only CaV interaction (1, 20, 21), and initial studies focused on RGK-CaV interactions—including possible regulation by binding to calmodulin (1) or 14-3-3 proteins (3). All of these studies indicated that RGK regulation of ICa,L involves CaV, but the contribution of CaV1.2 remains to be explored. PKA modulation is a physiologically important mechanism of Ca channel function in diverse excitable tissues such as heart muscle and pancreatic beta cells. PKA increases Ca current via phosphorylation of a serine residue on the COOH terminus distal to the calmodulin interaction sites of CaV1.2 (8). Using pharmacological and site-directed mutagenesis approaches, we tested the hypothesis that Rem block of Ca channel expression is not an all-or-none effect but rather a regulated process. Our results show that the CaV1.2 COOH terminus, in particular, serine 1928 (S1928) on the COOH terminus, contributes to Rem reduction of Ca current. This property is recapitulated in two divergent native cell systems, suggesting a novel and Address for reprint requests and other correspondence: J. Satin, Dept. of Physiology, MS-508, Univ. of Kentucky College of Medicine, 800 Rose St. Lexington, KY 40536-0298 (e-mail: [email protected]). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. cardiac myocyte; monomeric GTPase; Rad and Gem/Kir-related family; insulin-secreting cell; calcium imaging; heart development http://www.ajpheart.org 0363-6135/06 $8.00 Copyright © 2006 the American Physiological Society H1959 Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Crump, Shawn M., Robert N. Correll, Elizabeth A. Schroder, William C. Lester, Brian S. Finlin, Douglas A. Andres, and Jonathan Satin. L-type calcium channel ␣-subunit and protein kinase inhibitors modulate Rem-mediated regulation of current. Am J Physiol Heart Circ Physiol 291: H1959 –H1971, 2006. First published April 28, 2006; doi:10.1152/ajpheart.00956.2005.—Cardiac voltage-gated L-type Ca channels (CaV) are multiprotein complexes, including accessory subunits such as CaV2 that increase current expression. Recently, members of the Rad and Gem/Kir-related family of small GTPases have been shown to decrease current, although the mechanism remains poorly defined. In this study, we evaluated the contribution of the L-type Ca channel ␣-subunit (CaV1.2) to CaV2-Rem inhibition of Ca channel current. Specifically, we addressed whether protein kinase A (PKA) modulation of the Ca channel modifies CaV2-Rem inhibition of Ca channel current. We first tested the effect of Rem on CaV1.2 in human embryonic kidney 293 (HEK-293) cells using the whole cell patch-clamp configuration. Rem coexpression with CaV1.2 reduces Ba current expression under basal conditions, and CaV2a coexpression enhances Rem block of CaV1.2 current. Surprisingly, PKA inhibition by 133 nM H-89 or 50 M Rp-cAMP-S partially relieved the Rem-mediated inhibition of current activity both with and without CaV2a. To test whether the H-89 action was a consequence of the phosphorylation status of CaV1.2, we examined Rem regulation of the PKA-insensitive CaV1.2 serine 1928 (S1928) to alanine mutation (CaV1.2-S1928A). CaV1.2-S1928A current was not inhibited by Rem and when coexpression with CaV2a was not completely blocked by Rem coexpression, suggesting that the phosphorylation of S1928 contributes to Rem-mediated Ca channel modulation. As a model for native Ca channel complexes, we tested the ability of Rem overexpression in HIT-T15 cells and embryonic ventricular myocytes to interfere with native current. We find that native current is also sensitive to Rem block and that H-89 pretreatment relieves the ability of Rem to regulate Ca current. We conclude that Rem is capable of regulating L-type current, that release of Rem block is modulated by cellular kinase pathways, and that the CaV1.2 COOH terminus contributes to Rem-dependent channel inhibition. H1960 REM GTPASE AND CALCIUM CHANNELS perhaps universal mechanism for long-term regulation of Ca current levels by the coordinated actions of RGK GTPases and the phosphorylation status of excitable cells. MATERIALS AND METHODS AJP-Heart Circ Physiol • VOL 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Adenoviral Rem production. Replication-deficient recombinant adenoviruses coexpressing green fluorescent protein (GFP) and wildtype Rem were constructed as described (20). HIT-T15 cells were infected at 1 ⫻ 107 placque-forming units/ml and analyzed 24 h postinfection, a time point that allowed maximal Rem protein expression (21). Plasmids and mutagenesis. CaV1.2 plasmid (kindly provided by Dr. T. Kamp, University of Wisconsin) was identical to the originally cloned full-length rabbit cardiac ␣1C-subunit (33) except for alternative splicing in domain IV S3 (47). CaV2a plasmid (kindly provided by Dr. E. Perez-Reyes, University of Virginia) was identical to rat (38) and contains the two cysteines residing in the D1 domain associated with palmitoylation. The CaV1.2 serine 1928 to alanine (S1928A) mutation was created by using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacturer’s instructions, using full-length CaV1.2 cloned into pCC1GW1H as template. Mutation of S1928 was verified by DNA sequence analysis. GFP-CaV1.2 was kindly provided by K. Beam (Colorado State University, Fort Collins, CO) and is fully described by Grabner et al. (27). For confocal microscopy, cells were fixed 2–3 days after transfection. Cells were washed three times with PBS supplemented with 1 mM CaCl2 and 1 mM MgCl2 and then fixed in 4% paraformaldehyde on ice for 20 min. Cells were then washed three times with PBS and mounted on slides with Vectashield. For examination of GFP-CaV1.2 distribution, GFP-CaV1.2 was expressed alone, coexpressed with either hemagglutinin (HA)-tagged Rem or Flag-tagged CaV2a, or coexpressed with both HA-tagged Rem and Flag-tagged CaV2a. GFP-CaV1.2 was visualized by using a Leica laser scanning confocal inverted microscope equipped with argon laser to excite the cells at 488 nm and emission long-pass filtering ⬎505 nm. The cellular distribution of GFP-Rem was examined by using a similar experimental protocol, except that GFP-Rem was expressed alone, cotransfected with a vector expressing untagged CaV1.2 or Flag-tagged CaV2a, or coexpressed with both untagged CaV1.2 and Flag-tagged CaV2a. Electrophysiology. HEK-293 cells were transiently transfected with plasmids 12– 48 h before recordings were performed, as previously described (55). Transfected cells were identified by the expression of GFP. The whole cell configuration of the patch-clamp technique was used to measure ionic current. Patch electrodes with resistances of 1–2 M⍀ contained (in mM) 110 K-gluconate, 40 CsCl, 3 EGTA, 1 MgCl2, 5 Mg-ATP, and 5 HEPES, pH 7.36. The bath solution for HEK cells consisted of (in mM) 140 (or 102.5) CsCl, 2.5 (or 40) BaCl2 or CaCl2, 1 MgCl2, 10 tetraethylammonium-Cl, and 5 HEPES, pH 7.4. For embryonic ventricular myocytes, the normal Tyrode solution contained 140 NaCl, 1.8 CaCl2, 1 MgCl2, 5.4 KCl, 10 glucose, and 10 HEPES, pH 7.4. The Na-free bath was 150 N-methyl-D-glucamine, 2.5 BaCl2, 1 MgCl2, 10 HEPES, 10 glucose, and 5 4-aminopyridine, pH 7.4. Signals were amplified with an Axopatch 200B amplifier and 333 kHz A/D system (Axon Instruments, Union City, CA). Data were analyzed with Clampfit 8 (Axon Instruments) and Origin statistical software (OriginLab, Northampton, MA). There was no difference in the Rem inhibition of Ca2⫹ channel current amplitude for either Ca2⫹ or Ba2⫹ as the charge carrier. All recordings were performed at room temperature (20 –22°C). We used post hoc Student’s t-test to test for significance between control and experimental groups. Chronic H-89 is defined as 133 nM H-89 added at the time of plasmid transfection in HEK-293 cells. This concentration was maintained 18 –24 h. Immediately before recording was performed, H-89 was washed out. The washout period ranged from 11 to 30 min. Current-voltage (I-V) relationships were evaluated by voltageclamp protocols consisting of 5-s duration holding potential at ⫺80 mV followed by test depolarizations ranging from ⫺90 to ⫹60 in 5-mV increments with a 5-s interpulse interval. Test depolarization duration was either 225 ms (Figs. 1, 3, 4, and 5) or 800 ms in later experiments (Fig. 6). This protocol was initiated ⬎2 min after patch break and was repeated at least twice to confirm stability of the amplitude. Each protocol required ⬃3 min to complete. Embryonic ventricular myocyte tissue harvest or cell culture. All animals and animal procedures used in this study were approved by the University of Kentucky Institutional Animal Care and Use Committee. E10 mouse (ICR outbred strain, Harlan) hearts were dissected free of connective tissues, and ventricles were separated from conotruncus and sinus venosus. For cell electrophysiology, cells were enzymatically dispersed and cultured as previously described (15). Briefly, 10 – 40 embryos were minced and quickly transferred to nominally Ca-free digestion buffer containing 0.5 mg/ml collagenase (type II, Worthington) and 1 mg/ml pancreatin for two 15-min cycles. Digested tissue yielded a large fraction of single spontaneously beating cells in culture media consisting of DMEM ⫹ 10% FBS. Cells were infected with adenovirus at 100 multiplicity of infection within 24 h of dispersal. Adenoviral exposure was limited to 16 h. Adenovirus-infected cells were identified by GFP fluorescence and recorded 48 –72 h after initial viral exposure. To positively identify a cell as a cardiac myocyte, we relied on an embryonic ventricular myocyte ionic current signature primarily consisting of a large sodium current (INa) in normal Tyrode solution as our selection criterion. To isolate ICa,L, the bath was then changed to Na-free bath solution (see Embryonic ventricular myocyte tissue harvest). HIT-T15 cells were dispersed and infected similarly to embryonic ventricular myocytes, with the exception that HIT-T15 cell media consisted of Ham’s F-12 ⫹ 10% dialyzed horse serum ⫹ 2.5% FBS. Cytosolic calcium imaging. Cardiac myocytes were loaded with 2 M fura-2 AM for 8 min in a 10% CO2 incubator and then deesterified in Tyrode solution for ⬃20 min. Spontaneous Ca transients were recorded from the annulus of the photometry tube focused on a single cell or a cell cluster. All recordings were performed at 37°C. The cells were excited with light of 340-nm and 380-nm wavelengths. The images obtained at 340 nm and 380 nm were divided pixel by pixel, and the ratio data were reported. Data were collected and analyzed with IonOptix (Milton, MA) hardware and software. Additional offline transient analysis was performed with custom routines written in MatLab (Northampton, MA). Real-time RT-PCR. Total RNA was isolated by using the RNAqueous ⫺4PCR kit (Ambion) and quantitated spectrophotometrically at 260 nm. Contaminating genomic DNA was eliminated by DNase treatment (Ambion). A portion of the resulting RNA (1 g) was immediately used as a template for cDNA synthesis. Reverse transcription was performed with the use of the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen). Removal of genomic DNA was confirmed by preparing a no reverse transcription control for each sample. cDNA was then stored at ⫺20°C. Purified Rem-GFP plasmid (19) was quantified by using the PicoGreen (Molecular Probes) quantification method. With the molecular weight of the plasmid and insert known, it was possible to calculate the copy number. Knowing the copy number and concentration of plasmid DNA, the precise number of molecules added to subsequent real-time PCR runs was calculated. Real-time PCR was performed in 96-well optical plates in triplicate using an ABI 7700 Sequence Detector. Samples (0.2 ng cDNA) were prepared using the TaqMan PCR core reagent kit (Applied Biosystems), with the following primer and probe sets: GAPDH: forward 5⬘-ATGTTCCAGTATGACTCCACTCACG3⬘, reverse 5⬘-GAAGACACCAGTAGACTCCACGACA, probe 5⬘FAM-AAGCCCATCACCATCTTCCAGGAGCGAGA-TAMRA-3⬘; Ca V 1.2: forward 5⬘-CACCGTCTCCACCTTCGAA-3⬘, reverse 5⬘-CTTGTCTTCTGTGTGGGAGTCAAT-3⬘, probe 5⬘-FAMTGGCCAGAGCTGCTGTACCGCTC-TAMRA-3⬘; CaV2: forward H1961 REM GTPASE AND CALCIUM CHANNELS RESULTS Regulation of Ca channel current by Rem. It is now established that Rem inhibits ICa,L and that Rem interacts with CaV (20, 21), but the question of whether L-type channel ␣-subunit contributes to Rem regulation of ICa,L is unexplored. Therefore, we initially tested the effect of Rem on ICa in the absence of exogenous CaV expression. CaV1.2 expressed alone traffick to the plasma membrane (26) and allows measurement of Ba current (Fig. 1A). Rem coexpression significantly decreases peak inward current density by 64% compared with CaV1.2 expressed alone [from 10.3 ⫾ 1.9 (n ⫽ 15) to 3.7 ⫾ 0.5; P ⫽ 0.003; n ⫽ 14; Table 1]. The I-V relationship shows no Rem-induced-shift of peak current or obvious voltage dependence (Fig. 1A). Coexpression of CaV2a with CaV1.2 increases peak current density approximately 10-fold and shifts the peak voltage approximately ⫺10 mV (compare Fig. 1, A and B). In contrast to the partial block of ICa by Rem alone, coexpression of Rem, CaV2a, and CaV1.2 results in the complete absence of detectable current (20). The time course of current decay is an index of CaV2a regulation of CaV1.2 function. Figure 1C shows the current time course for CaV1.2 alone superimposed on that coexpressed with Rem; Fig. 1D shows the well-established inactivation slowing induced by CaV2a. At 200 ms after the onset of the depolarization, ⬃75% of the peak current remains for CaV1.2 alone, and Rem coexpression had no effect on inactivation kinetics (Fig. 1, C and E). In contrast, coexpression of CaV1.2 with CaV2a slows the time course of macroscopic current inactivation (Fig. 1, D and Fig. 1. Rem partially blocks L-type voltage-gated Ca (CaV) channel CaV1.2 but completely eliminates CaV1.2 ⫹ CaV2a current expression. A and B: currentvoltage (I-V) curve for CaV1.2 ⫹ Rem- (A) or CaV1.2 ⫹ CaV2a ⫹ Rem- (B) expressing cells. Number of cells tested is listed in parenthesis; 40 mM bath Ba2⫹. C and D: time course of inactivation is slower with coexpression of CaV2a. Average of current traces for Vtest ⫹ 20 mV from cells expressing CaV1.2 ⫾ Rem (C) or CaV1.2 ⫹ CaV2a ⫹ Rem (D) normalized and superimposed. E: pooled remaining current at 200 (r200); r200 is defined as fraction of current at 200 ms/peak current. Coexpression of CaV2a significantly retards inactivation; *P ⬍ 0.001. AJP-Heart Circ Physiol • VOL 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 5⬘-CATTTGCAGTTCGGACCAATG-3⬘, reverse 5⬘-GCACCGGAACGTCATCCT-3⬘, probe 5⬘-FAM-CAGATACAGCGCAGCCTAMRA-3⬘; Rem: forward 5⬘-GCGCCTACGTCATCGTGTACT-3⬘, reverse 5⬘-TCCGAGGCGCTCTCAAAG-3⬘, probe 5⬘-FAMCATAGCGGATCGCAGCA-TAMRA-3⬘. Samples were cycled for 50 cycles using an ABI 7700 Sequence Detector (Applied Biosystems). Cycle conditions were as follows: 2 min at 50°C, 10 min at 95°C followed by 50 cycles of 15 s at 95°C, and 1 min at 60°C. A standard curve was generated from dilutions of the Rem plasmid by plotting the natural log of the threshold cycle (CT) against the natural log of the number of molecules. The CT was defined as the cycle at which a statistically significant increase in the magnitude of the signal generated by the PCR reaction was first detected. CT was calculated under default settings for the real-time sequence detection software (Applied Biosystems). To maximize accuracy, dilutions were made over the range of copy numbers that included the amount of target cDNA expected in the experimental cDNA samples. Specific calcium channel component cDNA molecules present in the experimental cDNA were calculated from the standard curve. H1962 REM GTPASE AND CALCIUM CHANNELS Table 1. Current densities of HEK-293 and HIT-T15 cells HEK-293 Cells 40 mM Ba CaV1.2 (n) CaV1.2 ⫹ Rem (n) CaV1.2 ⫹ 2a (n) CaV1.2 ⫹ 2a ⫹ Rem (n) CaV1.2 (wild type) CaV1.2 ⫹ 2a (S1928A) CaV1.2 ⫹ 2a (S1928A) ⫹ H-89 ⫺10.3⫾1.9 (15) ⫺7.7⫾2.2 (5) ⫺4.5⫾2.5 (6) ⫺3.7⫾0.5 (14) ⫺7.0⫾1.9 (13) ⫺8.3⫾1.8 (9) ⫺102⫾21 (7) ⫺59.0⫾11.2 (6) ⫺61.4⫾20.9 (6) 0.0⫾0 (42) ⫺3.2⫾1.1 (16) ⫺3.4⫾(11) HIT-T15 Cells 40 mM Ba HIT-T15 (n) HIT-T15 ⫹ H-89 (n) Ad.control Ad.Rem ⫺29.5⫾6.8 (7) 0.0⫾0 (8) ⫺13.7⫾4.0 (7)* ⫺5.6⫾1.0 (11)† E). Thus macroscopic inactivation kinetics is an index of functional association of CaV2a with CaV1.2. CaV2a has predominant plasma membrane localization (49). It has been suggested that CaVs, in general, function by masking an endoplasmic reticulum retention domain on CaV1.2 (5), although recent studies of CaV suggest that the original model must be refined to account for both Src homology 3 and GK domains of CaV that are required to reconstitute ␣-subunit trafficking (50). Given our recent unpublished finding that Rem interacts with the GK domain of CaV2 (B. S. Finlin, R. Correll, C. Pang, S. M. Crump, J. Satin, and D. A. Andres, unpublished observation), it then follows that Rem may decrease CaV1.2 plasma membrane localization by interfering with the CaV1.2-CaV interaction. There are, however, three mitigating arguments against this model: 1) CaV2aCaV1.2-␣-interacting domain (AID) interaction is in the lownanometer range (41), and Rem is incapable of competing with CaV1.2-AID for CaV2a (B. S. Finlin, R. Correll, C. Pang, S. M. Crump, J. Satin, and D. A. Andres, unpublished observation); 2) surface biotinylation studies show CaV1.2 at the plasma membrane even in the presence of overexpressed Rem2 (21); and 3) labeled peptide toxin studies showed cell surface expression of CaV2.2 in the presence of exogenous Rem2 expression (9). We tested this further by measuring the fluorescence distribution of transiently transfected cells expressing GFP-CaV1.2 fusion protein alone, coexpressed with either Flag-tagged CaV2a or HA-tagged Rem, or coexpressing both Flag-CaV2a and HA-Rem. Figure 2 (top), shows the distribution of GFP-CaV1.2. Fluorescence is punctate and excluded from the nucleus. GFP-CaV1.2 ⫹ CaV2a coexpression, a condition that yields ionic current, does not show enriched plasma membrane localization. Most importantly, the fluorescence pattern of GFP-CaV1.2 is unchanged regardless of coexpression of CaV2a, Rem, or the combination of CaV2a Fig. 2. Visualization of localization of green fluorescent protein (GFP)-CaV1.2 and GFP-Rem. Top: central optical slice through cells transfected with GFP-CaV1.2 and coexpressing the indicated recombinant proteins. Leftmost panel demonstrates localization of GFP-CaV1.2 cotransfected with empty expression vectors, and remaining panels display a representative micrograph of GFP-CaV1.2 coexpressed with either Flag-tagged CaV2a, hemagglutinin (HA)-tagged Rem, or expressing both Flag-CaV2a and HA-Rem. GFP-CaV1.2 fluorescence is punctuate, excluded from the nucleus, and only minor amounts of the protein are located at cell periphery. Coexpressed proteins have little effect on GFP-CaV1.2 distribution. Bottom: central optical slice through cells transfected with GFP-Rem and coexpressing indicated recombinant proteins. GFP-Rem is enriched at cell periphery, although fluorescence is located throughout cell interior and is both punctate and diffuse. Coexpression of either CaV1.2 or CaV2a has no effect on fluorescence distribution. AJP-Heart Circ Physiol • VOL 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Values are means ⫾ SE (in pA/pF); (n), no. of cells tested. Peak inward current density is for Vtest ⫹ 20 mV. HEK, human embryonic kidney; CaV, L-type voltage-gated Ca; S1928A, serine 1928 to alanine mutation; Ad.control, cells infected with a control adenovirus expressing green fluorescent protein alone; Ad.Rem, cells infected with an adenovirus coexpressing wild-type Rem and green fluorescent protein. *P ⫽ 0.0003, †P ⫽ 0.0004, for HIT-T15 with H-89 treatment vs. HIT-T15 without H-89 treatment. H1963 REM GTPASE AND CALCIUM CHANNELS and Rem. GFP-Rem fluorescence is enriched in the plasma membrane, although a mixture of diffuse and punctate fluorescence is noted in the cytosol (Fig. 2, bottom). As with GFPCaV1.2, GFP-Rem fluorescence is not influenced by coexpression of Flag-CaV2a, untagged CaV1.2, or the combined coexpression of CaV2a and CaV1.2. Thus a portion of Rem is expressed at the cell surface regardless of CaV2a expression. We conclude that Rem does not necessarily block trafficking to the cell surface, and we note that HEK-293 cells may be inappropriate for quantitative cell-sorting studies with these channels because of the ectopic localization of overexpressed protein. With the finding that CaV1.2, CaV2a, and Rem all may populate surface membrane to some extent, we therefore focused this study on determining possible modulatory mechanisms of Rem effects on Ca channel current. CaV1.2 COOH terminus is required for Rem block of Ca2⫹ channel current. The carboxyl terminus of CaV1.2 contains several important modulatory domains, most notably PKA/ PKC substrate at position S1928 (18, 53). Deletion of the CaV1.2 COOH terminus distal to residue 1733 (CaV1.2⌬1733) yields a channel with ⬃50% plasma membrane localization compared with full length (25) but with CaM regulation intact. CaV1.2⌬1733 preserves the EF hand and the A, C, and IQ motif required for CaM interaction but omits the PKA phosphorylation site of CaV1.2 (18). Coexpression of CaV1.2⌬1733 with CaV2a resulted in current that was ⬃25% peak ICa compared with wild-type CaV1.2. In stark contrast to wild type, however, coexpression of CaV2a ⫹ Rem with CaV1.2⌬1733 failed to completely inhibit current. Although mean current Fig. 4. H-89 rapidly runs down current but does not alter the inactivation time course. A: peak CaV1.2 ⫹ CaV2a current plotted as a function of H-89 exposure time. B: representative current traces superimposed from 6-, 10-, 14-, and 18min exposure times. Note the indistinguishable time course of inactivation. AJP-Heart Circ Physiol • VOL 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Fig. 3. Distal carboxyl terminus is required for Rem elimination of Ca channel current amplitude. Current-voltage (I-V) relations for deletion of CaV1.2 COOH terminus distal to residue 1733 (CaV1.2⌬1733)coexpressed with CaV2a (solid squares) or with CaV2a ⫹ Rem (open circles) are not significantly different. was reduced, it was not statistically different from that in the absence of Rem coexpression (Fig. 3). The key important finding is that Rem-CaV2a fails to block current of the COOH-terminal truncated CaV1.2 channel. This suggests that the COOH terminus of CaV1.2 distal to position 1733 contributes to Rem regulation of Ca channel current. PKA inhibition relieves Rem inhibition of Ca current expression. To explore the contribution of the CaV1.2 COOH terminus to Rem-dependent regulation of Ca channel current, we next examined the involvement of PKA signaling to this process. In HEK-293 cells, PKA may be constitutively active (39). Thus we next tested the effect of acute PKA inhibition on Ca channel current. Figure 4A shows that H-89 progressively decreases Ba current, without altering the inactivation kinetics (Fig. 4B). This finding is consistent with the notion that CaV1.2 is constitutively modulated by active PKA in HEK-293 cells. We next performed a series of experiments to test whether the phosphorylation state of CaV1.2 modulates Rem regulation of Ca channels. Although H-89 modulation of Ca channel current occurs within seconds, the Rem obliteration of detectable current may occur over the hours of de novo channel complex formation. Therefore, we first treated transfected HEK-293 cells for ⬃18 h with H-89 (133 nM) to test whether steps leading to reduced channel function were governed by H-89-sensitive and Remsensitive processes. Given that acute H-89 exposure severely reduces current [Fig. 4 (39)], we then washed out H-89 20 – 45 min before initiating patch-clamp recordings. Chronic H-89 exposure reduced CaV1.2 ionic current. In contrast, chronic H-89 pretreatment prevented Rem inhibition of peak ICa (Fig. 5A). Although H-89 tended to increase peak current density in Rem ⫹ CaV1.2-expressing cells compared with cells expressing CaV1.2 alone, this difference was not significant. Neither the peak I-V relationship nor current kinetics was altered by chronic H-89 in Rem ⫹ CaV1.2-expressing cells (Fig. 5, A, D, and G). These data suggest that Rem-mediated channel blockade of CaV1.2 current is enhanced by an H-89-sensitive modulation of CaV1.2. Thus, in the presence of Rem GTPase, PKA activity can decrease, rather than increase, current. Rem block of current expression is complete when coexpressed with CaV2a. We therefore extended our studies to evaluate whether H-89 can override this profound block of CaV1.2 current in HEK cells coexpressing Rem ⫹ CaV2a. Overnight incubation of cells with H-89 reduces CaV1.2 ⫹ CaV2a current (measured after 20 – 45 min washout) 67% (from 25.7 ⫾ 2.5 to 8.5 ⫾ 5.3 pA/pF; data for 2.5-mM Ba H1964 REM GTPASE AND CALCIUM CHANNELS control current not shown). This fractional decrease is in parallel with experiments in the absence of CaV2a (Figs. 1A and 5A, solid squares), and these data suggest that the H-89 fractional current reduction is independent of CaV2a coexpression. Rem ⫹ CaV2a coexpression completely blocks current, and H-89 reduces current in the absence of Rem. Thus it is surprising that H-89 incubation partially relieved the Rem-CaV2a block of current expression (Fig. 5B). As higher concentrations of H-89 have been reported to inhibit kinases in addition to PKA, we repeated these experiments with RpcAMP-S, a second relatively selective competitive inhibitor of PKA. H-89 and Rp-cAMP-S (applied for ⬎18 h) had similar actions, namely, restoration of detectable current with Rem ⫹ CaV2a coexpression (Fig. 5, B and C). The current restored by H-89 had kinetics that inactivated with the same time course as that observed in the absence of CaV2a expression (Fig. 5, AJP-Heart Circ Physiol • VOL E and H). Given that H-89 has no effect on inactivation kinetics, but CaV2a coexpression does, the data suggest that H-89 restores CaV1.2 current with CaV2a functionally dissociated with respect to channel kinetics modification. This kinetic distinction differs from the Rp-cAMP-S restored current (Fig. 5, F and I); however, H-89 may have targets in addition to PKA. Status of PKA phosphorylation site on CaV1.2 modulates Rem regulation of Ca channels. A well-documented substrate for PKA phosphorylation of CaV1.2 is serine 1928, located on the COOH terminus of the channel (18, 23). To evaluate the specificity of our pharmacological experiments, we next tested Rem regulation of the CaV1.2 PKA phosphorylation-deficient mutant (CaV1.2-S1928A). Peak current density of CaV1.2S1928A was ⬃75% of that for wild-type ␣-subunit (Table 1). Rem coexpression had no effect on current density of CaV1.2- 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Fig. 5. PKA inhibition regulates Rem block of CaV1.2 current. Chronic (18 h) H-89 pretreatment restores CaV1.2 ionic current expression even in the presence of Rem coexpression. H-89 was present for ⬎18 h but was removed for 20 – 45 min before recording was performed and was absent during current recordings. A: peak current density for cells expressing CaV1.2 (solid squares) or CaV1.2 ⫹ Rem (open circles). B: peak current density of CaV1.2 ⫹ CaV2a (solid squares) or CaV1.2 ⫹ CaV2a ⫹ Rem (open circles). C: same as B except 50 M Rp-cAMP-S (RPc) was used instead of H-89. D–F: current traces are normalized and superimposed for Vtest ⫽ ⫹30 mV corresponding to conditions in A, and Vtest⫽ 0 mV corresponding to conditions in B and C. G–I: pooled r200 for conditions corresponding to those in A–C. REM GTPASE AND CALCIUM CHANNELS H1965 S1928A (Fig. 6A), and H-89 incubation had no further effect (Fig. 6B). Figure 6C illustrates the difference in response to Rem coexpression for wild-type versus S1928A mutant ␣-subunit. As seen with the wild-type channels, CaV2a coexpression slows macroscopic current decay of the S1928A mutant channel (Fig. 6, D and G). However, Rem coexpressed with CaV2a resulted in inactivation kinetics that was intermediate between CaV2a slowing and that for CaV1.2 alone (Fig. 6E). In summary, these data show that Rem-dependent regulation of the S1928A mutant channel is significantly different from the wild-type channel (Fig. 6C), and these differences are consisAJP-Heart Circ Physiol • VOL tent with the notion that the phosphorylation of CaV1.2 enhances Rem block of ICa,L. Modulation in native cells. Ca channels are a complex of several proteins. Therefore, we next sought native cell systems to confirm results from the simplified heterologous expression of Ca channels in HEK-293 cells. HIT-T15 cells are insulinsecreting cells that express predominantly CaV1.2 (30, 44). These cells express consistent levels of Ca current, are efficiently infected with recombinant adenoviruses, and are easily cultured for several days. First, to test the ability of Rem protein to inhibit CaV1.2 current, we infected cells with either 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Fig. 6. CaV1.2 phosphorylation site serine 1928 (S1928) contributes to Rem regulation of CaV1.2 current. In all panels, PKA phosphorylation-deficient CaV1.2 mutant S1928 to alanine (S1928A) is expressed. A: Rem has no effect on CaV1.2-S1928A current. Peak current density-voltage plot of CaV1.2-S1928A (solid squares) and CaV1.2-S1928A ⫹ Rem (open circles). B: same as A, except cells were pretreated 18 h with H-89. C: peak current density-voltage plot of CaV1.2-S1928A ⫹ CaV2a ⫹ Rem with H-89 pretreatment (open squares) and without H-89 (open circles) compared with wild-type CaV1.2 ⫹ CaV2a ⫹ Rem (closed squares). Rem block of wild-type channel coexpressed with CaV2a is complete, and thus Rem-CaV2a block of CaV1.2-wild-type channel current is significantly greater than that of CaV1.2-S1928A. D–F: current traces normalized and superimposed for Vtest ⫽ ⫹30 mV. Conditions are as labeled in legends. G: pooled r200 data. CaV2a significantly slows inactivation of CaV1.2-S1928A. With Rem coexpression, inactivation kinetics is intermediate between that which is characteristic for ␣ alone versus ␣ ⫹ CaV2a. Number of cells tested indicated in bars. H1966 REM GTPASE AND CALCIUM CHANNELS Vtest 0 mV ICa,L ⫽ ⫺3.1 ⫾ 0.6 pA/pF, or ⫺0.5 ⫾ 0.2 pA/pF for Ad.control or Ad.Rem, respectively, P ⫽ 0.02; Fig. 9D). We next tested for the ability of long-term H-89 exposure to reverse Rem-induced ICa,L inhibition. For these studies, H-89 was applied for 6 h to Ad.Rem-infected cells, media containing H-89 were removed 30 – 60 min before recording was performed, and recordings were initiated in the absence of H-89. After H-89 pretreatment, Ad.Rem-infected cells compared with Ad.control cells exhibited ICa,L peak amplitudes that tended to be larger but were statistically indistinguishable from those for Ad.control cells (Fig. 9E). One point of complexity is that mouse embryonic ventricular myocytes express multiple Ca channel types, principally, ICa,L carried by CaV1.2 (45), and T-type Ca current (ICa,T) carried by CaV3.1d (15). Ba2⫹ as the charge carrier and EGTA in the pipette dramatically slows macroscopic ICa,L decay but does not appreciably alter voltagedependent inactivation of ICa,T (14). In embryonic ventricular myocytes, ICa,T inactivates with a time constant of ⬃14 ms for Vtest positive to ⫺30 mV (7, 15, 42). To eliminate possible ICa,T contamination, we therefore replotted the I-V relationship with isochronal current 80 ms after onset of Vtest to allow for ⬎95% inactivation of ICa,T. The isochronal I-V shows larger ICa,L in Ad.Rem cells pretreated with H-89 compared with those that were not treated. Taken together with the heterologous expression studies, we therefore conclude that the phosphorylation status of CaV1.2 is an important contributor to Rem block of Ca channel current in native cells. DISCUSSION This study demonstrates a novel mechanism for L-type Ca channel functional regulation. Rem ⫹ CaV coexpression completely blocks Ca channel current in HEK-293 cells (1, 20), but Rem-CaV2a-inhibited current can be restored by either pharmacological inhibition of PKA signaling (H-89 or Rp-cAMP-S) or site-directed mutagenesis of the PKA phosphorylation site within the CaV1.2 subunit (S1928A). Treatment with H-89 and Rp-cAMP-S yields slightly different basal current, suggesting the possibility of additional cellular targets beyond PKA. Nonetheless, two pharmacological manipulations and the results with the S1928A mutant share PKA as a common effector. Thus we suggest that the phosphorylation status of CaV1.2 contributes to Rem regulation of the Ca channel complex. The second principal finding is that Rem, in the absence of exogenous CaV expression, can inhibit CaV1.2 current. The third major finding is that, in a pancreatic -cell line and in primary cultures of isolated cardiac embryonic Fig. 7. Rem partially inhibits native Ca channel current, and H-89 pretreatment inhibits RGK regulation of Ca channel current. A: current density-voltage relationship of HIT-T15 cells infected with adenovirus coexpressing wild-type Rem and GFP (Ad.Rem; 0 pA/pF, n ⫽ 8; open circles) or control adenovirus expressing GFP alone (Ad.control; 29.5 ⫾ 6.8 pA/pF, n ⫽ 7, solid squares). B: treatment of infected cells with H-89 inhibits Rem attenuation of current. (Ad. Rem ⫹ H-89, 5.6 ⫾ 1.0 pA/pF; n ⫽ 11, open circles; or Ad.control ⫹ H-89, 13.7 ⫾ 4.0 pA/pF, n ⫽ 7, solid squares; P ⫽ 0.0004.) AJP-Heart Circ Physiol • VOL 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 a control adenovirus expressing GFP alone (Ad.control) or an adenovirus coexpressing wild-type Rem and GFP (Ad.Rem). Figure 7A shows that Rem overexpression completely blocks Ca channel current in HIT-T15 cells. Our heterologous expression studies suggest that PKA inhibition should decrease the control current but should act to reverse Rem-mediated current inhibition. Figure 7B shows current-voltage curves demonstrating that, in the presence of H-89 pretreatment, there is Ca channel current despite exogenous Rem expression. The decrease of current by H-89 under control conditions (compare closed squares of Fig. 7, A and B) is anticipated on the basis of a reduced phosphorylation of CaV1.2 by inhibition of PKA. Thus an H-89-sensitive pathway plays a crucial role in Remdependent Ca channel regulation in this cell line. Embryonic ventricular myocytes express mRNA for Rem and CaV2 (Fig. 8A) and thus are a desirable native model system to address the complex interplay between Rem and ionic current. Adenovirus-mediated Rem overexpression results in ⬎3 order of magnitude increase of Rem mRNA but caused no significant changes in CaV2, CaV1.2, or NaV1.5 mRNA. Rem overexpression inhibits spontaneous beating and Ca transients (Fig. 8, B and C). In Ad.control-infected embryonic ventricular myocytes, 17 of 21 cells exhibited spontaneous global Ca transients (Table 2). In contrast, Ad.Reminfected embryonic ventricular myocytes failed to display spontaneous Ca transients in all cells tested (n ⫽ 21; Table 2). Nifedipine (10 M) also inhibits spontaneous Ca transients in control cell clusters (not shown). This confirms the essential role of CaV1.2 and/or 1.3 channels for spontaneous activity. To determine the minimum H-89 pretreatment duration required to release Rem block of Ca channel current, we incubated cells for 1 h, followed with a washout period of at least 45 min, and observed spontaneous Ca transients in only 1 of 6 cell clusters tested (Table 2). However, a 2-h H-89 pretreatment, followed by 20- to 25-min washout period, restored spontaneous Ca transients in embryonic ventricular myocytes infected with Ad.Rem (Fig. 8D and Table 2). These results are consistent with that observed in heterologous expression (Figs. 1– 6) and HIT cell studies (Fig. 7) and show that an H-89-sensitive pathway modulates Rem regulation of Ca channels on a rather slow timescale. To directly measure ICa,L, we voltage clamped single cells in the whole cell configuration. Representative Ad.control-infected cell currents are shown in Fig. 9A. The current noticeably activates at ⬃⫺25 mV and decays slowly with sustained depolarization. Infection of cells with Ad.Rem significantly reduces ICa,L compared with that from Ad.control cells (for H1967 REM GTPASE AND CALCIUM CHANNELS ventricular myocytes, exogenous Rem blocks ICa,L, and longterm treatment with H-89 can reverse this effect. A key principle is that PKA modulation of Rem block of ICa,L is occurring over a relatively long time frame compared with well-studied acute channel modulation by PKA. Interestingly, our data suggest that, in the long term, PKA enhances Rem block of ICa,L, and this is opposite the well-characterized effect of acute PKA stimulation of ICa,L. Bimodal modulation of CaV1.2 by PKA. Acute activation of PKA increases CaV1.2 current and is reversible by acute addition of H-89 (37, 39). The rapid rundown in the presence of H-89 has previously been interpreted as a consequence of Table 2. Ca2⫹ transient kinetic parameters Treatment Tested Calcium Transient Present Ad.control Ad.control ⫹ H89 (2-h pretreatment) Ad.Rem Ad.Rem ⫹ H-89 (2-h pretreatment) Ad.Rem ⫹ H-89 (1-h pretreatment) 21 17 21 14 6 17 15 0 10 1 t50, s 0.207⫾0.013 0.187⫾0.016 0.448⫾0.035 0.401⫾0.044 0.318⫾0.021 0.424⫾0.016* 0.211⫾0.010 0.225 0.382⫾0.018 0.673 0.396⫾0.048 0.333 Values are means ⫾ SE. TTP, time to peak of an individual Ca2⫹ transient; t50, time for 50% decay. *P ⫽ 0.02. AJP-Heart Circ Physiol • VOL Frequency, Hz TTP, s 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Fig. 8. Ad.Rem-infected embryonic ventricular myocytes effects on mRNA levels and spontaneous Ca transients. A: Ad.Rem increases Rem expression ⬎103-fold but has no significant effect on CaV2, NaV1.5, or CaV1.2 mRNA levels as measured by RT-PCR. B–D: spontaneous Ca transients manifested as ratio of fluorescence at 340 nm to fluorescence at 380 nm (340/380) in Ad.control-infected embryonic ventricular myocytes (B), Ad.Rem-infected embryonic ventricular myocytes (C), or Ad.Rem-infected embryonic ventricular myocytes that were pretreated with 133 nM H-89 (D). Note that H-89 restores transients in Ad.Rem-infected embryonic ventricular myocytes that are indistinguishable from those in control conditions. Sweeps in B and C are 30 s. Kinetic parameters of individual calcium transients are listed in Table 2. D: individual 10-s duration sweeps are concatenated. Solid vertical lines denote end and beginning of individual 10-s duration sweeps. Note that resting Ca2⫹ increases at 25 min post-H-89 washout, and spontaneous transients commence beginning with the 30-min recording. H1968 REM GTPASE AND CALCIUM CHANNELS dephosphorylation of a protein in the Ca channel complex (39). However, our data support a model in which PKA phosphorylation of CaV1.2 promotes Rem-mediated block of Ca channel current. These findings suggest that PKA has bimodal effects on Ca channel current. In the face of relatively high Rem expression, S1928 phosphorylation promotes a paradoxical decrease of current. In the absence of Rem, S1928 phosphorylation causes a well-described increase of current (Fig. 5). Thus PKA signaling serves to enhance Ca currents via direct phosphorylation of the channel complex but also plays an essential role in RGK GTPase family-dependent negative regulation of L-type Ca channel activity. We speculate that longterm Rem downregulation of ICa,L is a homeostatic regulator of current that is increased via PKA stimulation. Studies are ongoing to determine whether a similar mechanism serves to regulate other RGK family proteins. Mechanism of Rem block of Ca channel expression. CaV2 subunits promote trafficking of CaV ␣-subunits to the cell AJP-Heart Circ Physiol • VOL surface; in this regard, the palmitylated CaV2a is highly efficient (11). CaV2a also adds the distinctive functional feature of retarding voltage-dependent inactivation in heterologously expressed channels (26) and in native systems (12). In the absence of Ca2⫹, CaV2a-modified channels inactivate less than either CaV1.2 alone or CaV1.2 coexpressed with other CaV proteins. We therefore can use current decay kinetics as an index of CaV2a-␣-subunit functional interaction. For the wild-type channel coexpressed with Rem and CaV2a, the current that was restored by H-89 pretreatment tended to display decay kinetics reflective of ␣-subunit expression alone (Fig. 5). This would be consistent with models invoking either Rem blocking CaV2a-directed trafficking of ␣-subunit to the surface membrane or Rem preventing CaV2a modulation of a preformed ␣- channel complex at the surface membrane. In the former model, ␣-subunit-only Ca channels populate surface membrane. Support for the latter mechanism is the observation that the CaV1.2-S1928 mutant channel current has intermediate 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 Fig. 9. Rem inhibits ICa,L in embryonic ventricular myocytes, and Rem inhibition is antagonized by H-89 pretreatment. A: representative ionic current from Ad.control-infected embryonic ventricular myocyte cells for Vtest as shown in left column. B: representative current from Ad.Rem cells. C: representative current from Ad.Reminfected cells pretreated with 133 nM H-89. H-89 was removed before patch-clamp recording was performed and was absent for ⬎10 min. D: pooled peak inward I-V relationship for Ad.control superimposed on Ad.Rem. Peak currents at Vtest 0 mV are significantly decreased in Ad.Rem-infected cells (open circles; n ⫽ 4) compared with Ad.control (solid squares; n ⫽ 9; P ⫽ 0.01). E: pooled peak inward I-V relationship for Ad.Rem pretreated with 133 nM H-89 (upright triangles) compared with Ad.Rem (smooth line reproduced from D). To eliminate any possible contribution of T-type Ca current, current was also measured and plotted for isochrone of 80 ms after onset of Vtest (inverted triangles; n ⫽ 9). Note restoration of isochronal current with H-89 pretreatment (inverted triangles) despite Ad.Rem infection. REM GTPASE AND CALCIUM CHANNELS AJP-Heart Circ Physiol • VOL tions are shared by ICa,T, INa(13, 22), and hyperpolarizationactivated current If (40). Thus, in embryonic ventricular myocytes, ICa,L cannot be separated on the basis of voltage dependence but can be partially separated on the basis of kinetics. The key point is that kinetic-based separation requires the replacement of bath Ca2⫹ with Ba2⫹. With Ca2⫹ as the charge carrier, ICa,L fast inactivation overlaps with that of ICa,T, because of the relatively rapid Cadependent inactivation properties of the L-type Ca channel complex. However, ICa,L with Ba2⫹ as the charge carrier and with internal Ca buffered exhibits voltage-dependent decay that is ⬎10-fold slower than ICa,T. Finally, Ni2⫹ is known to block ICa,T but also has subunit composition-specific effects on ICa,L (54). Thus we did not use Ni2⫹ to discriminate between ICa,T and ICa,L in embryonic ventricular myocytes because of uncertainty of the effects of Ni2⫹ might have on the ICa,L of embryonic ventricular myocytes. Given the ambiguity of voltage dependence and potential nonselective effects of pharmacological reagents, we view Rem as an excellent discriminator between ICa,L and ICa,T. In heterologous expression systems, Rem blocks CaV1.2 channel current but has no effect on either CaV3.1 or CaV3.2 (20). Thus our finding that Rem blocks spontaneous Ca transients suggests that CaV1.2 channels contribute trigger Ca to Ca-induced Ca release in embryonic ventricular myocytes. Moreover, in the presence of CaV1.2, channel block by Rem ICa,T cannot compensate for L-type trigger Ca. Physiological consequences of PKA enhancement of RGKchannel effects. A recent study (34) showed that focal application of RGK can serve as an effective therapy for local Ca channel block in the heart. Our present work shows that PKA phosphorylation of the ␣-subunit would be expected to enhance such block. Murata et al. (34) allude to a potential benefit of RGK block of Ca current in ailments such as hypertrophic cardiomyopathy. However, a common first-line treatment of hypertrophic cardiomyopathy and other related cardiac disorders often includes administration of -adrenergic receptor blockade (48). Given our present results, -blockade would reduce the ability of Rem, and perhaps all RGK proteins, to inhibit Ca channel. Thus RGK as a Ca-entry blocking therapy may, in fact, be quite desirable, and our findings suggest that RGK therapy would have more effect for a sympathetic nervous system-stimulated heart. The original observation that linked RGK to CaV was in insulin-secreting cells (1). Although controversial, the most convincing evidence shows that CaV1.2 is the essential secretagogue in insulin-secreting cells (43, 46). Nutrient stimulation of insulin-secreting cells results in a well-established increase of cytosolic cAMP. This, in turn, results in cascades that, among the downstream targets, include increased PKA activity that increases Ca channel opening (see Ref. 35 for a review). Our results show that RGK in insulin-secreting cells add a negative feedback pathway to PKA-induced increases in Ca current. Indeed, our recent analysis of Rem2 function in -islet cell function supports such a model (21). In summary, we show evidence for a novel mechanism by which PKA stimulation can paradoxically decrease L-type Ca current. We conclude that the phosphorylation status of CaV1.2 is a contributor to RGK inhibition of Ca channel current. 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 inactivation kinetics when compared with either ␣-subunit alone or ␣ ⫹ CaV2a-expressed ICa. The inclusive explanation is that both general mechanisms of current block may exist. The data regarding a trafficking-related mechanism remain controversial. Recent biochemical studies with another RGK family member, Rem2, demonstrate that Rem2 does not prevent cell surface accumulation of CaV1.2 (21) and CaV2.2 (9), but contradictory results obtained by surface immunofluorescence were reported by others for Rad and Rem (4), Rem2 (2), and Kir/Gem (3). We suggest that this immunostaining technique may be less sensitive to low levels of cell surface expression than the other techniques. Our justification for this speculation is that CaV1.2 expressed alone in HEK-293 cells shows ionic current, but CaV1.2 cell surface expression is not detectable in the HA-immunostaining assay used by Beguin and colleagues (3). Thus RGK proteins do not necessarily block Ca2⫹ channel current by preventing transport to the plasma membrane. CaV ␣- subunit interaction stoichiometry is 1:1 (17), and recent studies show CaV2a enhances Ca channel modulation via secondary binding sites (31). This notion is consistent with our data suggesting that CaV1.2, particularly the phosphorylation of the COOH-terminal S1928, may contribute to the combined Rem-CaV modulation of ICa,L. In our working model, we suggest that a putative CaV2a-Rem-CaV1.2 complex is enhanced by CaV1.2 phosphorylation. In such a dynamic model, there are theoretically four possible channel combinations: a complex of ␣--Rem, ␣-, ␣- alone, or ␣-Rem. ␣--Rem should yield no current and ␣- will yield large-amplitude current with slow inactivation, whereas ␣-Rem or ␣- alone would yield small current with faster inactivation. Why then does ␣(S1928A)--Rem yield current with intermediate kinetics? The simplest explanation is that S1928 phosphorylation status enhances -Rem-mediated current blockade, and in the absence of phosphorylation of ␣-S1928, -Rem is less likely to complex with ␣- to completely block current. Thus we speculate that the functional impact of Rem in complex with the channel is to inhibit channel gating and channel kinetics, in part, via modulation of accessory subunit interactions. A second noncompeting idea is that Rem may function to promote retrograde transport, thus destabilizing plasma membrane localization of the Ca channel complex. Impetus for this suggestion is the ⬎1-h time course of H-89 required for restoration of current (Table 2). This suggests the possible presence of a cycling pool of Ca channel complexes that exhibit H-89-sensitive regulation. The data from our present study motivate future studies to delineate the mechanisms revealed by RGK block, and H-89 release of Rem block of Ca channel current. Contribution of ICa,L to embryonic ventricular myocyte function. In mature, nonpathological heart cells, CaV1.2 apparently is the only voltage-gated Ca channel underlying ICa,L, whereas ICa,T is reexpressed in adult pathological states (36). In adult myocytes, as in heterologous expression systems, ICa,L and ICa,T can be separated by either the relatively high- versus low-voltage activation range or by altering holding potential. However, in embryonic ventricular myocytes, ICa,T activates at higher potential and thus overlaps with the activation range of ICa,L (15). ICa,L also shows inactivation dependence that overlaps with ICa,T. Such depolarizing shifts of voltage dependence in embryonic ventricular myocytes compared with mature prepara- H1969 H1970 REM GTPASE AND CALCIUM CHANNELS ACKNOWLEDGMENTS We thank Tim Kamp (University of Wisconsin) for CaV1.2 and CaV2a, and Kurt Beam (University of Connecticut) for GFP-CaV1.2. GRANTS This study was supported by National Institutes of Health Grants HL074091 (to J. Satin), HL-072936 (to D. A. Andres), and P-20RR20171-Centers of Biomedical Research Excellence program of National Center for Research Resources (to D. A. Andres); ADA award (to B. Finlin); and American Heart Association predoctoral fellowship (to R. N. Correll). J. Satin is an Established Investigator of the American Heart Association. REFERENCES AJP-Heart Circ Physiol • VOL 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 1. Beguin P, Nagashima K, Gonoi T, Shibasaki T, Takahashi K, Kashima Y, Ozaki N, Geering K, Iwanaga T, and Seino S. Regulation of Ca2⫹ channel expression at the cell surface by the small G-protein kir/Gem. Nature 411: 701–706, 2001. 2. Beguin P, Mahalakshmi RN, Nagashima K, Cher DH, Kuwamura N, Yamada Y, Seino Y, and Hunziker W. Roles of 14-3-3 and calmodulin binding in subcellular localization and function of the small G protein Rem2. Biochem J 390: 67–75, 2005. 3. Beguin P, Mahalakshmi RN, Nagashima K, Cher DH, Takahashi A, Yamada Y, Seino Y, and Hunziker W. 14-3-3 And calmodulin control subcellular distribution of Kir/Gem and its regulation of cell shape and calcium channel activity. J Cell Sci 118: 1923–1934, 2005. 4. Beguin P, Mahalakshmi RN, Nagashima K, Cher DH, Ikeda H, Yamada Y, Seino Y, and Hunziker W. Nuclear sequestration of betasubunits by Rad and Rem is controlled by 14-3-3 and calmodulin and reveals a novel mechanism for Ca2⫹ channel regulation. J Mol Biol 355: 34 – 46, 2006. 5. Bichet D, Cornet V, Geib S, Carlier E, Volsen S, Hoshi T, Mori Y, and De Waard M. The I-II loop of the Ca2⫹ channel alpha1 subunit contains an endoplasmic reticulum retention signal antagonized by the beta subunit. Neuron 25: 177–190, 2000. 6. Brice NL, Berrow NS, Campbell V, Page KM, Brickley K, Tedder I, and Dolphin AC. Importance of the different beta subunits in the membrane expression of the alpha1A and alpha2 calcium channel subunits: studies using a depolarization-sensitive alpha1A antibody. Eur J Neurosci 9: 749 –759, 1997. 7. Burgess DE, Crawford O, Delisle BP, and Satin J. Mechanism of inactivation gating of human T-type (low-voltage activated) calcium channels. Biophys J 82: 1894 –1906, 2002. 8. Catterall WA. Structure and regulation of voltage-gated Ca2⫹ channels. Annu Rev Cell Dev Biol 16: 521–555, 2000. 9. Chen H, Puhl HL, 3rd Niu SL, Mitchell DC, and Ikeda SR. Expression of Rem2, an RGK family small GTPase, reduces N-type calcium current without affecting channel surface density. J Neurosci 25: 9762–9772, 2005. 10. Chien AJ, Zhao X, Shirokov RE, Puri TS, Chang CF, Sun D, Rios E, and Hosey MM. Roles of a membrane-localized beta subunit in the formation and targeting of functional L-type Ca[IMAGE] channels. J Biol Chem 270: 30036 –30044, 1995. 11. Chien AJ, Carr KM, Shirokov RE, Rios E, and Hosey MM. Identification of palmitoylation sites within the L-type calcium channel beta 2a subunit and effects on channel function. J Biol Chem 271: 26465–26468, 1996. 12. Colecraft HM, Alseikhan B, Takahashi SX, Chaudhuri D, Mittman S, Yegnasubramanian V, Alvania RS, Johns DC, Marban E, and Yue DT. Novel functional properties of Ca2⫹ channel beta subunits revealed by their expression in adult rat heart cells. J Physiol 541: 435– 452, 2002. 13. Conforti L, Tohse N, and Sperelakis N. Tetrodotoxin-sensitive sodium current in rat fetal ventricular myocytes– contribution to the plateau phase of action potential. J Mol Cell Cardiol 25: 159 –173, 1993. 14. Cribbs LL, Lee JH, Yang J, Satin J, Zhang Y, Daud A, Barclay J, Williamson MP, Fox M, Rees M, and Perez-Reyes E. Cloning and characterization of ␣1H from human heart, a member of the T-type calcium channel gene family. Circ Res 83: 103–109, 1998. 15. Cribbs LL, Martin BL, Schroder EA, Keller BB, Delisle BP, and Satin J. Identification of the T-type calcium channel (CaV3.1d) in developing mouse heart. Circ Res 88: 403– 407, 2001. 16. Dai S, Klugbauer N, Zong X, Seisenberger C, and Hofmann F. The role of subunit composition on prepulse facilitation of the cardiac L-type calcium channel. FEBS Lett 442: 70 –74, 1999. 17. Dalton S, Takahashi SX, Miriyala J, and Colecraft HM. A single CaV can reconstitute both trafficking and macroscopic conductance of voltagedependent calcium channels. J Physiol 567: 757–769, 2005. 18. De Jongh KS, Murphy BJ, Colvin AA, Hell JW, Takahashi M, and Catterall WA. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3⬘,5⬘-cyclic monophosphate-dependent protein kinase. Biochemistry 35: 10392–10402, 1996. 19. Finlin BS and Andres DA. Rem is a new member of the Rad- and Gem/Kir Ras-related GTP-binding protein family repressed by lipopolysaccharide stimulation. J Biol Chem 272: 21982–21988, 1997. 20. Finlin BS, Crump SM, Satin J, and Andres DA. Regulation of voltagegated calcium channel activity by the Rem and Rad GTPases. Proc Natl Acad Sci USA 100: 14469 –14474, 2003. 21. Finlin BS, Mosley AL, Crump SM, Correll RN, Ozcan S, Satin J, and Andres DA. Regulation of L-type Ca2⫹ channel activity and insulin secretion by the Rem2 GTPase. J Biol Chem 280: 41864 – 41871, 2005. 22. Fujii S, Ayer RK Jr, and DeHaan RL. Development of the fast sodium current in early embryonic chick heart cells. J Membr Biol 101: 209 –223, 1988. 23. Gao T, Yatani A, Dell’Acqua ML, Sako H, Green SA, Dascal N, Scott JD, and Hosey MM. cAMP-dependent regulation of cardiac L-type Ca2⫹ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 19: 185–196, 1997. 24. Gao T, Chien AJ, and Hosey MM. Complexes of the alpha 1C and beta subunits generate the necessary signal for membrane targeting of class C L-type calcium channels. J Biol Chem 274: 2137–2144, 1999. 25. Gao T, Bunemann M, Gerhardstein BL, Ma H, and Hosey MM. Role of the C terminus of the alpha 1C (CaV1.2) subunit in membrane targeting of cardiac L-type calcium channels. J Biol Chem 275: 25436 –25444, 2000. 26. Gerster U, Neuhuber B, Groschner K, Striessnig J, and Flucher BE. Current modulation and membrane targeting of the calcium channel alpha1C subunit are independent functions of the beta subunit. J Physiol 517: 353–368, 1999. 27. Grabner M, Dirksen RT, and Beam KG. Tagging with green fluorescent protein reveals a distinct subcellular distribution of L-type and non-L-type Ca2⫹ channels expressed in dysgenic myotubes. Proc Natl Acad Sci USA 95: 1903–1908, 1998. 28. Gurnett CA, De Waard M, and Campbell KP. Dual function of the voltage-dependent Ca2⫹ channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron 16: 431– 440, 1996. 29. Hofmann F, Biel M, and Flockerzi V. Molecular basis for Ca2⫹ channel diversity. Annu Rev Neurosci 17: 399 – 418, 1994. 30. Ji J, Yang SN, Huang X, Li X, Sheu L, Diamant N, Berggren PO, and Gaisano HY. Modulation of L-type Ca(2⫹) channels by distinct domains within SNAP-25. Diabetes 51: 1425–1436, 2002. 31. Leroy J, Richards MS, Butcher AJ, Nieto-Rostro M, Pratt WS, Davies A, and Dolphin AC. Interaction via a key tryptophan in the I-II linker of N-type calcium channels is required for 1 but not for palmitoylated 2, implicating an additional binding site in the regulation of channel voltagedependent properties. J Neurosci 25: 6984 – 6996, 2005. 32. Letts VA, Felix R, Biddlecome GH, Arikkath J, Mahaffey CL, Valenzuela A, Bartlett FS, 2nd Mori Y, Campbell KP, and Frankel WN. The mouse stargazer gene encodes a neuronal Ca2⫹-channel gamma subunit. Nat Genet 19: 340 –347, 1998. 33. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S, and Numa S. Primary structure and function expression of the cardiac dihydropyridine-sensitive calcium channel. Nature 340: 230 – 233, 1989. 34. Murata M, Cingolani E, McDonald AD, Donahue JK, and Marban E. Creation of a genetic calcium channel blocker by targeted gem gene transfer in the heart. Circ Res 95: 398 – 405, 2004. 35. Newgard CB and McGarry JD. Metabolic coupling factors in pancreatic beta-cell signal transduction. Annu Rev Biochem 64: 689 –719, 1995. 36. Nuss HB and Houser SR. T-type Ca2⫹ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73: 777–782, 1993. 37. Ono K and Fozzard HA. Phosphorylation restores activity of L-type calcium channels after rundown in inside-out patches from rabbit cardiac cells. J Physiol 454: 673– 688, 1992. 38. Perez-Reyes E, Castellano A, Kim HS, Bertrand P, Baggstrom E, Lacerda AE, Wei XY, and Birnbaumer L. Cloning and expression of a cardiac/brain beta subunit of the L-type calcium channel. J Biol Chem 267: 1792–1797, 1992. REM GTPASE AND CALCIUM CHANNELS AJP-Heart Circ Physiol • VOL 47. Slish DF, Engle DB, Varadi G, Lotan I, Singer D, Dascal N, and Schwartz A. Evidence for the existence of a cardiac specific isoform of the alpha 1 subunit of the voltage dependent calcium channel. FEBS Lett 250: 509 –514, 1989. 48. Spirito P, Seidman CE, McKenna WJ, and Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 336: 775–785, 1997. 49. Takahashi SX, Mittman S, and Colecraft HM. Distinctive modulatory effects of five human auxiliary beta(2) subunit splice variants on L-type calcium channel gating. Biophys J 84: 3007–3021, 2003. 50. Takahashi SX, Miriyala J, Tay LH, Yue DT, and Colecraft HM. A CaVbeta SH3/guanylate kinase domain interaction regulates multiple properties of voltage-gated Ca2⫹ channels. J Gen Physiol 126: 365–377, 2005. 51. Wei Sk Colecraft HM, DeMaria CD, Peterson BZ, Zhang R, Kohout TA, Rogers TB, and Yue DT. Ca2⫹ channel modulation by recombinant auxiliary  subunits expressed in young adult heart cells. Circ Res 86: 175–184, 2000. 52. Yamaguchi H, Okuda M, Mikala G, Fukasawa K, and Varadi G. Cloning of the beta(2a) subunit of the voltage-dependent calcium channel from human heart: cooperative effect of alpha(2)/delta and beta(2a) on the membrane expression of the alpha(1C) subunit. Biochem Biophys Res Commun 267: 156 –163, 2000. 53. Yang L, Liu G, Zakharov SI, Morrow JP, Rybin VO, Steinberg SF, and Marx SO. Ser1928 is a common site for Cav1.2 phosphorylation by protein kinase C isoforms. J Biol Chem 280: 207–214, 2005. 54. Zamponi GW, Bourinet E, and Snutch TP. Nickel block of a family of neuronal calcium channels: subtype and subunit-dependent action at multiple sites. J Membr Biol 151: 77–90, 1996. 55. Zhang Y, Cribbs LL, and Satin J. Arachidonic acid modulation of ␣1H, a cloned human T-type calcium channel. Am J Physiol Heart Circ Physiol 278: H184 –H193, 2000. 291 • OCTOBER 2006 • www.ajpheart.org Downloaded from http://ajpheart.physiology.org/ by 10.220.33.4 on June 14, 2017 39. Perez-Reyes E, Yuan W, Wei X, and Bers DM. Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett 342: 119 –123, 1994. 40. Qu J, Altomare C, Bucchi A, DiFrancesco D, and Robinson RB. Functional comparison of HCN isoforms expressed in ventricular and HEK 293 cells. Pflügers Arch 444: 597– 601, 2002. 41. Richards MW, Butcher AJ, and Dolphin AC. Ca2⫹ channel betasubunits: structural insights AID our understanding. Trends Pharmacol Sci 25: 626 – 632, 2004. 42. Satin J and Cribbs LL. Identification of a T-type calcium channel isoform in murine atrial myocytes (AT-1). Circ Res 86: 636 – 642, 2000. 43. Schulla V, Renstrom E, Feil R, Feil S, Franklin I, Gjinovci A, Jing XJ, Laux D, Lundquist I, Magnuson MA, Obermuller S, Olofsson CS, Salehi A, Wendt A, Klugbauer N, Wollheim CB, Rorsman P, and Hofmann F. Impaired insulin secretion and glucose tolerance in beta cell-selective Cav1.2 Ca2⫹ channel null mice. EMBO J 22: 3844 –3854, 2003. 44. Seino S, Chen L, Seino M, Blondel O, Takeda J, Johnson JH, and Bell GI. Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells. Proc Natl Acad Sci USA 89: 584 –588, 1992. 45. Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kuhbandner S, Striessnig J, Klugbauer N, Feil R, and Hofmann F. Functional embryonic cardiomyocytes after disruption of the L-type alpha 1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem 275: 39193– 39199, 2000. 46. Sinnegger-Brauns MJ, Hetzenauer A, Huber IG, Renstrom E, Wietzorrek G, Berjukov S, Cavalli M, Walter D, Koschak A, Waldschutz R, Hering S, Bova S, Rorsman P, Pongs O, Singewald N, and Striessnig J. Isoform-specific regulation of mood behavior and pancreatic  cell and cardiovascular function by L-type Ca2⫹ channels. J Clin Invest 113: 1430 –1439, 2004. H1971
© Copyright 2026 Paperzz